Focus
Eli Lilly
Eli Lilly to Sell Weight Loss Drugs Directly to Patients
The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
Eli Lilly Launches Digital Health Care Platform to Help Patients With Chronic Disease
The new digital health care platform facilitates home delivery for patients, ensuring they have ‘consistent access’ to Lilly medicines.
Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
The company said it conducted tests on compounded drugs that claim to contain semaglutide and found ‘concerning levels of unknown impurities.’
Safety Concerns Loom as Obesity Drugs Head to Clinical Trials in Kids as Young as 6
As childhood obesity rates surge globally, pharma giants test weight loss drugs on kids despite safety concerns over side effects and long-term health impacts.
